{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:49:48Z","timestamp":1789051788923,"version":"build-2803163510"},"reference-count":73,"publisher":"Elsevier BV","issue":"21-22","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.cca.2010.08.003","type":"journal-article","created":{"date-parts":[[2010,8,11]],"date-time":"2010-08-11T08:50:19Z","timestamp":1281516619000},"page":"1625-1631","source":"Crossref","is-referenced-by-count":97,"title":["Triglycerides and gallstone formation"],"prefix":"10.1016","volume":"411","author":[{"given":"A.H.M.","family":"Smelt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2010.08.003_bb0005","doi-asserted-by":"crossref","first-page":"18B","DOI":"10.1016\/S0002-9149(98)00033-2","article-title":"Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome","volume":"81","author":"Grundy","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cca.2010.08.003_bb0010","first-page":"23","article-title":"Hyperinsulinaemia and hypertriglyceridaemia","volume":"736","author":"Steiner","year":"1994","journal-title":"J Intern Med Suppl"},{"key":"10.1016\/j.cca.2010.08.003_bb0015","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/BF00400640","article-title":"Changes of lipolytic enzymes cluster with insulin resistance syndrome. Botnia Study Group","volume":"38","author":"Knudsen","year":"1995","journal-title":"Diabetologica"},{"key":"10.1016\/j.cca.2010.08.003_bb0020","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2165\/00129784-200101060-00005","article-title":"Hypertriglyceridemia: associated risks and effect of drug treatment","volume":"1","author":"Jonkers","year":"2001","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.cca.2010.08.003_bb0025","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0022-2275(20)37571-4","article-title":"Heterozygosity for Asn291\u2013>Ser mutation in the lipoprotein lipase gene in two Finnish pedigrees: effect of hyperinsulinemia on the expression of hypertriglyceridemia","volume":"37","author":"Syvanne","year":"1996","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cca.2010.08.003_bb0030","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0022-2275(20)39760-1","article-title":"Prevalence of alleles encoding defective lipoprotein lipase in hypertriglyceridemic patients of French Canadian descent","volume":"36","author":"Minnich","year":"1995","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cca.2010.08.003_bb0035","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0021-9150(87)90190-0","article-title":"DNA polymorphisms of apolipoprotein A-I\/C-III and insulin genes in familial hypertriglyceridemia and coronary heart disease","volume":"66","author":"Aalto-Setala","year":"1987","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2010.08.003_bb0040","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1046\/j.1365-2362.1998.00361.x","article-title":"Increased risk for endogenous hypertriglyceridaemia is associated with an apolipoprotein C3 haplotype specified by the SstI polymorphism","volume":"28","author":"Hoffer","year":"1998","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.cca.2010.08.003_bb0045","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1161\/01.ATV.0000054194.78240.45","article-title":"Apolipoprotein A5: a newly identified gene that affects plasma triglyceride levels in humans and mice","volume":"23","author":"Pennacchio","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cca.2010.08.003_bb0050","first-page":"487","article-title":"The importance of plasma apolipoprotein E concentration in addition to its common polymorphism on inter-individual variation in lipid levels: results from Apo Europe","volume":"155","author":"Haddy","year":"2002","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.cca.2010.08.003_bb0055","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/S0022-2275(20)34905-1","article-title":"Association of the A-204C polymorphism in the cholesterol 7alpha-hydroxylase gene with variations in plasma low density lipoprotein cholesterol levels in the Framingham Offspring Study","volume":"40","author":"Couture","year":"1999","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cca.2010.08.003_bb0060","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/sj.ejhg.5201236","article-title":"Modulating effect of the A-278C promoter polymorphism in the cholesterol 7alpha-hydroxylase gene on serum lipid levels in normolipidemic and hypertriglyceridemic individuals","volume":"12","author":"Hofman","year":"2004","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.cca.2010.08.003_bb0065","first-page":"315","article-title":"Postreceptor insulin resistance contribute to human dyslipidemia and hepatic steatosis","volume":"119","author":"Semple","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cca.2010.08.003_bb0070","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1152\/physrev.00010.2008","article-title":"Role of bile acids and bile acid receptors in metabolic regulation","volume":"89","author":"Lefebvre","year":"2009","journal-title":"Physiol Rev"},{"key":"10.1016\/j.cca.2010.08.003_bb0075","doi-asserted-by":"crossref","first-page":"E2","DOI":"10.1111\/j.1749-6632.2009.04956.x","article-title":"From sugar to fat; how the transcription factor XBP1 regulates hepatic lipogenesis","volume":"1173","author":"Glimcher","year":"2009","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.cca.2010.08.003_bb0080","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.bcp.2008.11.026","article-title":"Liver X receptor modulators: effects on lipid metabolism and potential use in the treatment of atherosclerosis","volume":"77","author":"Fi\u00e9vet","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.cca.2010.08.003_bb0085","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/MOL.0b013e32832b3f4c","article-title":"FoxO1 and hepatic lipid metabolism","volume":"20","author":"Sparks","year":"2009","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.cca.2010.08.003_bb0090","first-page":"2347","article-title":"FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice","volume":"118","author":"Kamagate","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cca.2010.08.003_bb0095","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1194\/jlr.R800026-JLR200","article-title":"Fifty years of advances in bile acid synthesis and metabolism","volume":"50","author":"Russell","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cca.2010.08.003_bb0100","doi-asserted-by":"crossref","first-page":"28745","DOI":"10.1074\/jbc.M605815200","article-title":"Insulin regulation of cholesterol 7alpha-hydrolase expression in human hepatocytes: roles of forkhead box O1 and sterol regulatory element-binding protein 1c","volume":"281","author":"Li","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2010.08.003_bb0105","doi-asserted-by":"crossref","first-page":"43224","DOI":"10.1074\/jbc.M302645200","article-title":"Leptin induces the hepatic high density lipoprotein receptor scavenger receptor B type 1 (SR-B1) but not cholesterol 7\u03b1-hydrolase (Cyp7a1) in leptin-deficient (ob\/ob) mice","volume":"278","author":"Lund\u00e5sen","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2010.08.003_bb0110","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1194\/jlr.R900010-JLR200","article-title":"Bile acids: regulation of synthesis","volume":"50","author":"Chiang","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cca.2010.08.003_bb0115","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nrd2619","article-title":"Targeting bile-acid signaling for metabolic diseases","volume":"7","author":"Thomas","year":"2008","journal-title":"Nat Rev Drug Discovery"},{"key":"10.1016\/j.cca.2010.08.003_bb0120","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1101\/gad.1083503","article-title":"Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis","volume":"17","author":"Holt","year":"2003","journal-title":"Genes Dev"},{"key":"10.1016\/j.cca.2010.08.003_bb0125","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cmet.2005.09.001","article-title":"Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis","volume":"2","author":"Inagak","year":"2005","journal-title":"Cell Metab"},{"key":"10.1016\/j.cca.2010.08.003_bb0130","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/0026-0495(82)90231-1","article-title":"Effects of interruption of the enterohepatic circulation of bile acids on the transport of very low density-lipoprotein triglycerides","volume":"31","author":"Beil","year":"1982","journal-title":"Metabolism"},{"key":"10.1016\/j.cca.2010.08.003_bb0135","doi-asserted-by":"crossref","first-page":"5434","DOI":"10.1073\/pnas.84.15.5434","article-title":"Bile acid metabolism in hereditary forms of hypertriglyceridemia: evidence for an increased synthesis rate in monogenic familial hypertriglyceridemia","volume":"84","author":"Angelin","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cca.2010.08.003_bb0140","doi-asserted-by":"crossref","first-page":"45685","DOI":"10.1074\/jbc.M404255200","article-title":"Bile acid reduces the secretion of very low density lipoprotein by repressing microsomal triglyceride transfer protein gene expression mediated by hepatocyte nuclear factor-4","volume":"279","author":"Hirokane","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2010.08.003_bb0145","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1002\/hep.21616","article-title":"Increased activity of hepatic microsomal triglyceride transfer protein and bile acid synthesis in gallstone disease","volume":"45","author":"Castro","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.cca.2010.08.003_bb0150","unstructured":"Elzinga BM. Effects of bile salts on hepatic lipoprotein production (Dissertation). Groningen: Rijksuniversiteit, 2003."},{"key":"10.1016\/j.cca.2010.08.003_bb0155","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1172\/JCI109025","article-title":"The physical chemistry of cholesterol solubility in bile. Relationship to gallstone formation and dissolution in man","volume":"61","author":"Carey","year":"1978","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cca.2010.08.003_bb0160","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0889-8553(21)00535-5","article-title":"Gallbladder function in gallstone disease","volume":"20","author":"Everson","year":"1991","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.cca.2010.08.003_bb0165","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1172\/JCI110209","article-title":"Role of gallbladder mucus hypersecretion in the evolution of cholesterol gallstones","volume":"67","author":"Lee","year":"1981","journal-title":"J Clin Invest"},{"issue":"Suppl.2","key":"10.1016\/j.cca.2010.08.003_bb0170","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1046\/j.1365-2036.2000.014s2039.x","article-title":"Review: pathogenesis of gallstones","volume":"14","author":"Dowling","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cca.2010.08.003_bb0175","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/0140-6736(93)92479-D","article-title":"An explanation for gallstones in normal-weight women: slow intestinal transit","volume":"341","author":"Heaton","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2010.08.003_bb0180","first-page":"1291","article-title":"Increase of deoxycholate in supersaturatedbile of patients with cholesterol gallstone disease and its correlation with de novo synthesis of cholesterol and bile acids in liver, gallbladder emptying, and small intestinal transit","volume":"21","author":"Shoda","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.cca.2010.08.003_bb0185","doi-asserted-by":"crossref","first-page":"S406","DOI":"10.1194\/jlr.R800075-JLR200","article-title":"Biliary lipids and cholesterol gallstone disease","volume":"50","author":"Wang","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cca.2010.08.003_bb0190","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1016\/S0022-2275(20)41092-2","article-title":"Intrahepatic biliary cholesterol and phospholipid transport in humans: effect of obesity and cholesterol cholelithiasis","volume":"36","author":"Ahmed","year":"1995","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cca.2010.08.003_bb0195","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/oby.2002.46","article-title":"Body weight modulates cholesterol metabolism in non-insulin dependent type 2 diabetes","volume":"10","author":"Simonen","year":"2002","journal-title":"Obes Res"},{"key":"10.1016\/j.cca.2010.08.003_bb0200","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0022-2275(20)39758-3","article-title":"Abnormal bile acid absorption in familial hypertriglyceridemia","volume":"36","author":"Duane","year":"1995","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cca.2010.08.003_bb0205","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0016-5085(80)90079-7","article-title":"Biliary lipid composition in normo- and hyperlipoproteinemia","volume":"79","author":"Ahlberg","year":"1980","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cca.2010.08.003_bb0210","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/gut.52.1.109","article-title":"Gallbladder dysmotility: a risk factor for gallstone formation in hypertriglyceridemia. Reversal upon triglyceride-lowering therapy by both bezafibrate and fish-oil","volume":"52","author":"Jonkers","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.cca.2010.08.003_bb0215","first-page":"18","article-title":"Simultaneous determination of plasma mevalonate and 7-hydroxy-4-cholesten-3-one levels in hyperlipoproteinemia: convenient indices for estimating hepatic defects of cholesterol and bile acid syntheses and biliary cholesterol supersaturation","volume":"25","author":"Shoda","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.cca.2010.08.003_bb0220","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1172\/JCI107876","article-title":"Bile acid kinetics in relation to sex, serum lipids, body weight and gallbladder disease in patients with various types of hyperlipoproteinemia","volume":"54","author":"Einarsson","year":"1974","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cca.2010.08.003_bb0225","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/S0022-2275(20)33450-7","article-title":"Diminished gene expression of ileal apical sodium bile acid transporter explains impaired absorption of bile acid in patients with hypertriglyceridemia","volume":"41","author":"Duane","year":"2000","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cca.2010.08.003_bb0230","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0022-2275(20)40684-4","article-title":"Bile acid kinetics in relation to endogenous triglyceride metabolism in various types of hyperlipoproteinemia","volume":"19","author":"Angelin","year":"1978","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cca.2010.08.003_bb0235","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/0026-0495(81)90039-1","article-title":"The effect of weight reduction on biliary lipid metabolism in patients with hyperlipoproteinemia type IV","volume":"30","author":"Leijd","year":"1981","journal-title":"Metabolism"},{"key":"10.1016\/j.cca.2010.08.003_bb0240","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/hep.22204","article-title":"Coordinate regulation of gallbladder motor function in the gut-liver axis","volume":"47","author":"Portincasa","year":"2008","journal-title":"Hepatology"},{"issue":"Suppl.2","key":"10.1016\/j.cca.2010.08.003_bb0245","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1046\/j.1365-2036.2000.014s2066.x","article-title":"Review article: agents affecting gall-bladder motility \u2013 role in treatment and prevention of gallstones","volume":"14","author":"van Erpecum","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cca.2010.08.003_bb0250","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1210\/jc.2007-2787","article-title":"Effects of euglycemic hyperinsulinemia and lipid infusion on circulating cholecystokinin","volume":"93","author":"Weickert","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2010.08.003_bb0255","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/0016-5085(89)90392-2","article-title":"Gallbladder contraction in patients with pigment and cholesterol stones","volume":"97","author":"Behar","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cca.2010.08.003_bb0260","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1440-1746.1994.tb01272.x","article-title":"The effect of simvastatin and bezafibrate on bile composition and gall-bladder emptying in female non-insulin-dependent diabetics","volume":"9","author":"Wilson","year":"1994","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.cca.2010.08.003_bb0265","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/hep.1840160418","article-title":"Dietary N-3 polyunsaturated fatty acids decrease biliary cholesterol saturation in gallstone disease","volume":"16","author":"Berr","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.cca.2010.08.003_bb0270","first-page":"912","article-title":"Consensus for the use of fibrates in the treatment of dyslipoproteinemia and coronary heart disease. Fibrate Consensus Group","volume":"81","author":"Fruchart","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cca.2010.08.003_bb0275","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/sj.ejcn.1600768","article-title":"Dietary counseling effectively improves lipid levels in patients with endogenous hypertriglyceridemia: emphasis on weight reduction and alcohol limitation","volume":"53","author":"De Man","year":"1999","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.cca.2010.08.003_bb0280","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1124\/mol.108.052928","article-title":"Bezafibrate at clinically relevant doses decrease serum\/liver triglycerides via down-regulation of sterol regulatory element-binding protein-1c in mice: a novel peroxisome proliferator-activated receptor\u03b1 independent mechanism","volume":"75","author":"Nakajima","year":"2009","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.cca.2010.08.003_bb0285","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1023\/A:1005643014395","article-title":"Role of fibrates and HMG-CoA reductase inhibitors in gallstone formation: epidemiological study in an unselected population","volume":"46","author":"Caroli-Bosc","year":"2001","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cca.2010.08.003_bb0290","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0002-9343(87)90869-2","article-title":"Effects of fibric acid derivatives on biliairy lipid composition","volume":"83","author":"Palmer","year":"1987","journal-title":"Am J Med"},{"key":"10.1016\/j.cca.2010.08.003_bb0295","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/hep.510250623","article-title":"Hepatic cholesterol metabolism in human obesity","volume":"25","author":"Stahlberg","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.cca.2010.08.003_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/S0021-9150(98)00075-6","article-title":"The mechanism underlying the hypocholesterolemic effect of chronic fish oil feeding in rats is not due to increased excretion of dietary cholesterol","volume":"139","author":"Bravo","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2010.08.003_bb0305","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0022-2275(20)41219-2","article-title":"Dietary fish oil potentiates bile acid-induced cholesterol secretion into bile in rats","volume":"35","author":"Smit","year":"1994","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cca.2010.08.003_bb0310","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1172\/JCI115397","article-title":"Dietary fish oil-induced changes in intrahepatic cholesterol transport and bile acid synthesis in rats","volume":"8","author":"Smit","year":"1991","journal-title":"Clin Invest"},{"key":"10.1016\/j.cca.2010.08.003_bb0315","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0022-2275(20)36958-3","article-title":"Effect of dietary n-3 versus n-6 polyunsaturated fatty acids on hepatic excretion of cholesterol in the hamster","volume":"4","author":"Berr","year":"1993","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cca.2010.08.003_bb0320","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0022-2275(20)37444-7","article-title":"Dietary fats modulate the regulatory potential of dietary cholesterol on cholesterol 7 alpha-hydroxylase gene expression","volume":"38","author":"Cheema","year":"1997","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cca.2010.08.003_bb0325","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0014-5793(04)00049-3","article-title":"Dietary fish oil up-regulates cholesterol 7alpha-hydroxylase mRNA in mouse liver leading to an increase in bile acid and cholesterol excretion","volume":"559","author":"B\u00e9rard","year":"2004","journal-title":"FEBS Lett"},{"key":"10.1016\/j.cca.2010.08.003_bb0330","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1089\/1044549041562267","article-title":"Polyunsaturated fatty acids are FXR ligands and differentially regulate expression of FXR targets","volume":"23","author":"Zhao","year":"2004","journal-title":"DNA Cell Biol"},{"key":"10.1016\/j.cca.2010.08.003_bb0335","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1074\/jbc.270.10.5381","article-title":"Regulation of hepatic 7\u03b1-hydroxylase expression and response to dietary cholesterol in the rat and hamster","volume":"270","author":"Horton","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2010.08.003_bb0340","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/jn\/136.4.987","article-title":"Fish-oil increases bile acid synthesis in male patients with hypertriglyceridemia","volume":"136","author":"Jonkers","year":"2006","journal-title":"J Nutr"},{"key":"10.1016\/j.cca.2010.08.003_bb0345","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1074\/jbc.M008809200","article-title":"Peroxisome proliferator-activated receptor alpha is not rate-limiting for the lipoprotein-lowering action of fish oil","volume":"276","author":"Dallongeville","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2010.08.003_bb0350","doi-asserted-by":"crossref","first-page":"27i","DOI":"10.1016\/j.amjcard.2005.12.024","article-title":"Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids","volume":"98","author":"Davidson","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cca.2010.08.003_bb0355","doi-asserted-by":"crossref","first-page":"27855","DOI":"10.1074\/jbc.M008885200","article-title":"The triple threat to nascent apolipoprotein B","volume":"276","author":"Fisher","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2010.08.003_bb0360","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0140-6736(75)91845-0","article-title":"Clofibrate and gallstones","volume":"1","author":"Cooper","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2010.08.003_bb0365","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF01072597","article-title":"Clofibrate therapy and gallstone induction","volume":"23","author":"Bateson","year":"1978","journal-title":"Am J Dig Dis"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898110004997?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898110004997?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T16:04:43Z","timestamp":1636041883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898110004997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":73,"journal-issue":{"issue":"21-22","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0009898110004997"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2010.08.003","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}